Table 3.
Treatment Group |
P Value |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
3 mo |
9 mo |
Time | Tx | 3 mo vs 9 mo |
Saline vs Fluoxetine |
|||||
Saline (n = 8) | Fluoxetine (n = 7) | Saline (n = 8) | Fluoxetine (n = 7) | Saline | Fluoxetine | 3 mo | 9 mo | |||
Periosteal area, mm2 | 0.54 ± 0.06 | 0.41 ± 0.06 | 0.70 ± 0.06 | 0.69 ± 0.06 | 0.001 | 0.25 | 0.07 | 0.004 | 0.14 | 0.90 |
Periosteal circumference, mm | 3.09 ± 0.03 | 3.01 ± 0.04 | 3.31 ± 0.04 | 3.29 ± 0.03 | < 0.0001 | 0.19 | < 0.0001 | < 0.0001 | 0.14 | 0.73 |
C.Po, % | 0.089 ± 0.001 | 0.090 ± 0.002 | 0.097 ± 0.003 | 0.098 ± 0.001 | 0.003 | 0.85 | 0.02 | 0.05 | 0.74 | 0.95 |
C.Th, mm | 0.19 ± 0.003 | 0.19 ± 0.004 | 0.18 ± 0.006 | 0.18 ± 0.003 | 0.006 | 0.49 | 0.05 | 0.03 | 0.76 | 0.50 |
C.BMD, mg/cm3 HA | 1273 ± 9.18 | 1265 ± 7.83 | 1255 ± 11.66 | 1267 ± 8.28 | 0.42 | 0.87 | 0.18 | 0.86 | 0.53 | 0.38 |
Abbreviations: C.Po, cortical porosity; C.Th, cortical thickness; C.BMD, cortical bone mineral density; Tx, treatment.